From: Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008
 |  |  |  |  |  | Number of deaths prevented or postponed | Percentage of total reduction |  | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Treatments | Number of eligible patients | Patients receiving treatment (%) | Relative risk reduction (%) | Mean case-fatality (%) | Absolute risk reduction | Best estimate | Minimum estimate | Maximum estimate | Best estimate | Minimum estimate | Maximum estimate |
Acute MI | 91317 | Â | Â | 0.067 | Â | 1677 | 684 | 3309 | 4.7 | 1.9 | 9.3 |
Community CPR | 9132 | 100 | 0.05 | 0.067 | 0.055 | 443 | 283 | 638 | 1.2 | 0.8 | 1.8 |
Hospital CPR | 2740 | 6 | 0.32 | 0.067 | 0.323 | 53 | 34 | 91 | 0.1 | 0.1 | 0.3 |
Thrombolysis | 91317 | 29 | 0.26 | 0.067 | 0.014 | 316 | 130 | 656 | 0.9 | 0.4 | 1.8 |
Aspirin | 91317 | 93 | 0.15 | 0.067 | 0.010 | 774 | 317 | 1420 | 2.2 | 0.9 | 4.0 |
Beta blocker | 91317 | 70 | 0.04 | 0.067 | 0.003 | 143 | 59 | 296 | 0.4 | 0.2 | 0.8 |
ACE inhibitor | 91317 | 61 | 0.07 | 0.067 | 0.005 | 228 | 93 | 466 | 0.6 | 0.3 | 1.3 |
Primary PTCA | 91317 | 18 | 0.32 | 0.067 | 0.020 | 589 | 241 | 1221 | 1.6 | 0.7 | 3.4 |
Primary CABG | 91317 | 9 | 0.20 | 0.067 | 0.013 | 112 | 40 | 231 | Â | Â | Â |
MI treatments in 1995 subtracted | Â | Â | Â | Â | Â | -1244 | -599 | -2367 | 3.5 | 1.7 | 6.6 |
Unstable angina | Â | Â | Â | Â | Â | 639 | 364 | 1800 | 1.8 | 1.0 | 5.0 |
Aspirin & heparin | 45658 | 50 | 0.33 | 0.053 | 0.017 | 316 | 129 | 655 | 0.9 | 0.4 | 1.8 |
Aspirin alone | 45658 | 88 | 0.15 | 0.053 | 0.008 | 245 | 100 | 465 | 0.7 | 0.3 | 1.3 |
PG IIB/IIIA | 45658 | 41 | 0.09 | 0.053 | 0.005 | 70 | 28 | 144 | 0.2 | 0.1 | 0.4 |
CABG surgery for UA | 45658 | 13 | 0.43 | 0.053 | 0.023 | 107 | 44 | 221 | 0.3 | 0.1 | 0.6 |
PTCA for UA | 45658 | 26 | 0.32 | 0.053 | 0.016 | 152 | 62 | 314 | 0.4 | 0.2 | 0.9 |
Secondary Prev Post AMI | 759071 | Â | Â | 0.061 | Â | 4548 | 1454 | 6509 | 12.7 | 4.1 | 18.2 |
Aspirin | 759071 | 73 | 0.778 | 0.045 | 0.007 | 2170 | 711 | 3665 | 6.1 | 2.0 | 10.3 |
Beta blocker | 759071 | 63 | 0.526 | 0.045 | 0.010 | 2052 | 672 | 3713 | 5.7 | 1.9 | 10.4 |
ACE inhibitor | 759071 | 61 | 0.514 | 0.045 | 0.009 | 1771 | 580 | 3198 | 5.0 | 1.6 | 9.0 |
Statin | 759071 | 3 | 0.757 | 0.045 | 0.010 | 1339 | 351 | 2767 | 3.7 | 1.0 | 7.7 |
Warfarin | 759071 | 8 | 0.032 | 0.045 | 0.010 | 76 | 25 | 138 | 0.2 | 0.1 | 0.4 |
Secondary Prev Post CABG/PCI | 275652 | Â | Â | 0.006 | Â | 1752 | 575 | 4164 | 4.9 | 1.6 | 11.7 |
Aspirin | 273379 | 97 | 0.15 | 0.017 | 0.003 | 496 | 162 | 1076 | 1.4 | 0.5 | 3.0 |
Beta blocker | 273379 | 60 | 0.23 | 0.017 | 0.004 | 470 | 154 | 1167 | 1.3 | 0.4 | 3.3 |
ACE inhibitor | 273379 | 54 | 0.20 | 0.017 | 0.003 | 366 | 120 | 909 | 1.0 | 0.3 | 2.5 |
Statin | 273379 | 87 | 0.22 | 0.017 | 0.004 | 377 | 124 | 898 | 1.1 | 0.3 | 2.5 |
Warfarin | 273379 | 2.2 | 0.22 | 0.017 | 0.004 | 18 | 6 | 44 | 0.1 | 0.0 | 0.1 |
Rehabilitation | 273379 | Â | Â | Â | Â | 83 | 27 | 208 | 0.2 | 0.1 | 0.6 |
Chronic angina | Â | Â | Â | Â | Â | 3348 | 1105 | 8627 | 9.4 | 3.1 | 24.2 |
CABG surgery 1995-2008 | 103293 | 100 | 0.35 | 0.012 | 0.002 | 632 | 324 | 1093 | 1.8 | 0.9 | 3.1 |
CABG treatments in 1995 subtracted | 103293 | Â | Â | Â | Â | -6 | -4 | -8 | 0.0 | 0.0 | -0.1 |
Angioplasty 1996-2000 | 103293 | 100 | 0.00 | 0.022 | 0.000 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 |
Aspirin in community | 103293 | 78 | 0.15 | 0.012 | 0.001 | 2840 | 931 | 7066 | 8.0 | 2.6 | 19.8 |
Statins in community | 103293 | 63 | 0.23 | 0.012 | 0.003 | 1517 | 398 | 4530 | 4.2 | 1.1 | 12.7 |
Hospital heart failure | 46511 | Â | Â | 0.258 | Â | 1025 | 306 | 2756 | 2.9 | 0.9 | 7.7 |
ACE inhibitor | 46511 | 43 | 0.20 | 0.166 | 0.033 | 251 | 66 | 744 | 0.7 | 0.2 | 2.1 |
Beta blocker | 46511 | 37 | 0.35 | 0.166 | 0.058 | 378 | 99 | 1121 | 1.1 | 0.3 | 3.1 |
Spironolactone | 46511 | 40 | 0.30 | 0.166 | 0.051 | 510 | 167 | 1269 | 1.4 | 0.5 | 3.6 |
Aspirin | 46511 | 68 | 0.15 | 0.166 | 0.025 | 428 | 140 | 1041 | 1.2 | 0.4 | 2.9 |
Community heart failure | 424611 | Â | Â | 0.085 | Â | 2338 | 747 | 5961 | 6.5 | 2.1 | 16.7 |
ACE inhibitor | Â | 70 | 0.20 | 0.085 | 0.013 | 479 | 126 | 1430 | 1.3 | 0.4 | 4.0 |
Beta blocker | Â | 70 | 0.35 | 0.085 | 0.030 | 986 | 323 | 2453 | 2.8 | 0.9 | 6.9 |
Spironolactone | Â | 25 | 0.31 | 0.085 | 0.030 | 883 | 289 | 2197 | 2.5 | 0.8 | 6.1 |
Aspirin | Â | 90 | 0.15 | 0.085 | 0.013 | 924 | 303 | 2299 | 2.6 | 0.8 | 6.4 |
Statins | Â | 40 | 0.00 | 0.085 | 0.000 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 |
Hypertension treatment | 10029567 | 57 | 0.13 | 0.007 | 0.001 | 2153 | 356 | 4472 | 6.0 | 1.0 | 12.5 |
Statins for primary prevention | 6133187 | 2 | 0.35 | 0.006 | 0.002 | 41 | 11 | 205 | 0.1 | 0.0 | 0.6 |
Total treatment | Â | Â | Â | Â | Â | 16671 | 5356 | 35362 | 47.0 | 15.1 | 100.0 |